Cited by 231Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

Open access
Mackenzie, Ian R. A., Frick, Petra, Grässer, Friedrich A., Gendron, Tania F., Petrucelli, Leonard, Cashman, Neil R., Edbauer, Dieter, Kremmer, Elisabeth +3 more·2015·Acta Neuropathologica

Abstract

Hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of frontotemporal dementia and motor neuron disease. One consequence of the mutation is the formation of different potentially toxic polypeptides composed of dipeptide repeats (DPR) (poly-GA, -GP, -GR, -PA, -PR) generated by repeat-associated non-ATG (RAN) translation. While previous studies focusing on poly-GA pathology have failed to detect any clinico-pathological correlations in C9ORF72 mutation cases, recent data from animal and cell culture models suggested that it may be only specific DPR species that are toxic and only when accumulated in certain intracellular compartments. Therefore, we performed a systematic clinico-pathological correlative analysis with counting of actual numbers of distinct types of inclusion (neuronal cytoplasmic and intranuclear inclusions, dystrophic neurites) for each DPR protein in relevant brain regions (premotor cortex, lower motor neurons) in a cohort of 35 C9ORF72 mutation cases covering the clinical spectrum from those with pure MND, mixed FTD/MND and pure FTD. While each DPR protein pathology had a similar pattern of anatomical distribution, the total amount of inclusions for each DPR protein varied remarkably (poly-GA > GP > GR > PR/PA), indicating that RAN translation seems to be more effective from sense than from antisense transcripts. Importantly, with the exception of moderate associations for the amount of poly-GA-positive dystrophic neurites with degeneration in the frontal cortex and total burden of poly-GA pathology with disease onset, no relationship was identified for any other DPR protein pathology with degeneration or phenotype. Biochemical analysis revealed a close correlation between insoluble DPR protein species and numbers of visible inclusions, while we did not find any evidence for the presence of soluble DPR protein species. Thus, overall our findings strongly argue against a role of DPR protein aggregation as major and exclusive pathomechanism in C9ORF72 pathogenesis. However, this does not exclude that DPR protein formation might be essential in C9ORF72 pathogenesis in interplay with other consequences associated with the C9ORF72 repeat expansion.

Integrity signals

Registry

Crossref · 10.1007/s00401-015-1476-2

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., & Neumann, M.
Affiliations
  • University of British Columbia (CA)
  • German Center for Neurodegenerative Diseases (DE)
  • Saarland University (DE)
  • Mayo Clinic in Florida (US)
  • Helmholtz Munich (DE)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Neumann, Manuela
Venue
Acta Neuropathologica
Published
2015-09-15
Volume
130
Issue
6
Pages
845-861
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W1673222863
Cited by
231
References
47
Citations by year
2026: 9 · 2025: 9 · 2024: 10 · 2023: 18 · 2022: 19 · 2021: 27 · 2020: 29 · 2019: 40 · 2018: 27 · 2017: 19 · 2016: 21 · 2015: 3
FWCI
16.45
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Site cant be reached (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • Canadian Institutes of Health Research (CA) (74580)
  • Seventh Framework Programme (BE) (FP7/2014-2019)
  • Helmholtz Association (DE) (VH-VI-510, W2/W3-036)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72, hexanucleotide repeat expansion, dipeptide repeat proteins, repeat-associated non-ATG translation, frontotemporal dementia, motor neuron disease, dystrophic neurites, neuronal cytoplasmic inclusions, intranuclear inclusions, disease onset, clinicopathological correlation, premotor cortex, lower motor neurons
MeSH terms
C9orf72 Protein, Adult, Aged, Amyotrophic Lateral Sclerosis, Brain, DNA-Binding Proteins, Female, Fluorescent Antibody Technique, Heterozygote, Humans, Hypoglossal Nerve, Male, Middle Aged, Proteins, Severity of Illness Index, Spinal Cord, Tissue Banks, Immunoblotting, Motor Neuron Disease, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review